Physician
Firstchoice Family Care
Firstchoice Family Care was paid $1.78M by Medicaid between Jun 2020 and Dec 2024, across 76 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 43% of everything it billed.
33Billing provider infoFIRSTCHOICE FAMILY CARE
BYRDSTOWN, TN 38549
BYRDSTOWN, TN 38549
33aNPI1962961466assigned 03/14/2019
33bProvider typeFamily Medicine Physician
28Total paid$1.78M
24GClaims76,124
24DCodes billed76
24AFirst – last monthJun 2020 – Dec 2024
Compared with peers
Next to other Family Medicine Physician providers in Tennessee
Rank by total paid#35 of 754
Median peer was paid$34K
This provider vs. median53×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 5,375 | $101K | |
| 2021 | 14,596 | $361K | |
| 2022 | 18,814 | $431K | |
| 2023 | 19,352 | $470K | |
| 2024incomplete | 17,987 | $416K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 43% | 23,151 | 17,641 | $770K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 11% | 5,156 | 3,887 | $187K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 5.2% | 1,430 | 1,234 | $92K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 5.1% | 3,723 | 3,267 | $90K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 4.5% | 2,290 | 1,896 | $81K |
| 87428 | 4.3% | 1,945 | 1,641 | $77K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 4.3% | 2,892 | 2,444 | $77K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 4.3% | 1,277 | 1,157 | $76K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 3.8% | 2,490 | 2,188 | $67K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 3.7% | 7,308 | 3,195 | $66K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 2.7% | 1,363 | 1,052 | $48K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.6% | 3,066 | 2,111 | $29K |
64 more codes
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 1.3% | 436 | $24K |
| 90461 | 1.3% | 1,596 | $23K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 4,131 | $14K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 170 | $12K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 405 | $8K |
| 87807 | <1% | 748 | $6K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 275 | $5K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 440 | $4K |
| 99177 | <1% | 861 | $4K | |
| 92552 | <1% | 202 | $3K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 25 | $3K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 31 | $2K |
| 36415 | Collection of venous blood by venipuncture | <1% | 2,007 | $2K |
| 96127 | <1% | 378 | $1K | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 101 | $1K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 57 | $1K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 15 | $999.01 |
| 92558 | <1% | 182 | $702.98 | |
| 81001 | <1% | 500 | $687.75 | |
| 0031A | <1% | 36 | $560.00 | |
| 99173 | <1% | 48 | $443.50 | |
| 99307 | <1% | 82 | $422.47 | |
| 36416 | <1% | 252 | $374.05 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 262 | $357.51 |
| 81002 | <1% | 332 | $304.22 | |
| 90734 | <1% | 25 | $301.00 | |
| 90686 | <1% | 132 | $253.30 | |
| 71045 | Radiologic examination, chest; single view | <1% | 23 | $157.14 |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | <1% | 17 | $152.11 |
| 90697 | <1% | 106 | $146.59 | |
| 80061 | Lipid panel | <1% | 123 | $142.95 |
| 99308 | Subsequent nursing facility care, per day, straightforward | <1% | 22 | $135.70 |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 65 | $63.77 |
| 90715 | <1% | 42 | $50.00 | |
| 99406 | <1% | 19 | $47.67 | |
| 3078F | <1% | 278 | $40.06 | |
| 3077F | <1% | 90 | $40.00 | |
| J1010 | Injection, methylprednisolone acetate, 1 mg | <1% | 69 | $38.22 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 54 | $38.15 |
| 90633 | <1% | 216 | $38.00 | |
| 90688 | <1% | 48 | $37.54 | |
| 3074F | <1% | 339 | $30.11 | |
| 3079F | <1% | 226 | $30.06 | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 134 | $26.27 |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 28 | $20.53 |
| 81003 | <1% | 14 | $16.86 | |
| G0008 | Administration of influenza virus vaccine | <1% | 16 | $15.42 |
| 90670 | <1% | 918 | $0.03 | |
| 90648 | <1% | 133 | $0.01 | |
| 90698 | <1% | 253 | $0.01 | |
| 3075F | <1% | 87 | $0.01 | |
| 90723 | <1% | 147 | $0.01 | |
| 1159F | 0% | 285 | $0.00 | |
| 90710 | 0% | 32 | $0.00 | |
| 1160F | 0% | 394 | $0.00 | |
| 90707 | 0% | 13 | $0.00 | |
| 90619 | 0% | 22 | $0.00 | |
| 90680 | 0% | 418 | $0.00 | |
| 3008F | 0% | 1,336 | $0.00 | |
| 1036F | 0% | 139 | $0.00 | |
| 1034F | 0% | 131 | $0.00 | |
| 3080F | 0% | 23 | $0.00 | |
| 90716 | 0% | 13 | $0.00 | |
| 90696 | 0% | 31 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialGARRETT, JAMIE (PRACTICE MANAGER)